HPV vaccine Gardasil safe for teens, young women

10/1/2012 | Reuters

A study involving almost 190,000 girls and women ages 9 to 26 found no new safety concerns with Merck & Co.'s human papillomavirus vaccine Gardasil. Fainting and rare cases of skin infections, the only observed side effects, were expected and benign, according to researchers. The findings appear in the Archives of Pediatrics & Adolescent Medicine.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC